Digital Therapeutics Development
Digital Therapeutics (DTx) Development
DTx provides novel treatment options other than traditional medicine. For example, treatment of insomnia had traditionally been dependent on drugs, and it is well-known that there are widespread concerns among patients about the use of drug therapy. On the other hand, DTx based on cognitive-behavioral therapy aims to change fundamentally patients’ ways of thinking and daily habits, which lead to insomnia.
We are developing DTx for diseases with room for the development of treatment methods other than those used to date.
We are developing DTx for diseases with room for the development of treatment methods other than those used to date.
Product Pipeline
DTx Co-Development
In addition to our own development seeds, we are also developing DTx in collaboration with business partners.
As part of this initiative, we have developed DTx development platform called QDTx, which reduces the time and man-hours required to develop a DTx. Validating the efficacy of a DTx and obtaining proof of concept (PoC) involve repeatedly scrapping and rebuilding the app. For this reason, the process of developing a DTx takes a considerable amount of time and involves considerable cost. However, QDTx accelerates the scrap-and-build cycle and makes it easier, greatly enhancing the efficiency of DTx development carried out together with our business partners.
As part of this initiative, we have developed DTx development platform called QDTx, which reduces the time and man-hours required to develop a DTx. Validating the efficacy of a DTx and obtaining proof of concept (PoC) involve repeatedly scrapping and rebuilding the app. For this reason, the process of developing a DTx takes a considerable amount of time and involves considerable cost. However, QDTx accelerates the scrap-and-build cycle and makes it easier, greatly enhancing the efficiency of DTx development carried out together with our business partners.
Index
Next Contents